LyGenesis Announces a New Peer-Reviewed Publication Expanding its Liver Regeneration Technology
/PRNewswire/ -- LyGenesis, a clinical-stage biotechnology company developing cell therapies for patients with end stage liver disease, Type 1 diabetes, end...
Source: prnewswire.com